85%
improvement in overall skin comfort severity score vs placebo
100% of participants progressed to mild skin discomfort rating by week 12.
110.7% greater improvement in affected skin surface area vs placebo.
How does a single oral botanical achieve this?
In a 12-week double-blind randomised controlled trial, subjects taking Eczefolia® at 200 mg per day began showing measurable improvement in skin comfort within 12 days.
Not after months. Not after completing the full trial.
Twelve days.
Our talk at NutraFocus
What Clinically Proven Innovation for Eczema & Skin Comfort
When 2 September 2026 · 11:00–11:30 AM (Bangkok time)
Where NutraFocus Stage · QSNCC, Bangkok
Booth Visit us at #P01, Hall 3 Main Entrance · 2–4 September
In 30 minutes, our head of R&D, Dr. Faiqah will explain
The Mechanism
Why oral delivery of Melicope ptelefolia reaches where topical creams cannot
The Technology
The patent-pending resin extraction behind Eczefolia®’s standardised acetophenone profile
The Methodology
How the 12-week double-blind placebo-controlled trial was designed and what it measured
The Sourcing Story
Why Malaysia’s rainforest produces a tHGA & tHPA profile that cannot be replicated anywhere else on earth
On 2 September, our R&D head Dr. Faiqah answers that question live at the NutraFocus stage, Vitafoods Asia 2026, Bangkok.
20 years in the making
Could a Malaysian rainforest herb bring real, steroid-free comfort to eczema-prone skin? For two decades, that single question drove our scientists. On 2 September, you will hear the answer live.
Come for the data. Stay for the story. Whether you are formulating for sensitive skin, exploring steroid-free positioning, or simply curious how a traditional botanical became a clinically studied ingredient and our team would be glad to walk you through it.
